PMC:7755033 / 74274-74477 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7755033","sourcedb":"PMC","sourceid":"7755033","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7755033","text":"e\nProcainamide\nCinacalcet\n12.5. Best docking poses of WS phytoconstituents with SARS-CoV main protease/3CL-pro (PBB ID: 1P9U) in comparison to the FDA approved standard reference drugs (Oberadilol and Po","divisions":[{"label":"tr","span":{"begin":2,"end":14}},{"label":"td","span":{"begin":2,"end":15}},{"label":"tr","span":{"begin":15,"end":25}},{"label":"td","span":{"begin":15,"end":26}}],"tracks":[{"project":"LitCovid-sentences","denotations":[{"id":"T701","span":{"begin":2,"end":14},"obj":"Sentence"},{"id":"T702","span":{"begin":15,"end":25},"obj":"Sentence"},{"id":"T703","span":{"begin":26,"end":31},"obj":"Sentence"},{"id":"T704","span":{"begin":32,"end":119},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T701","pred":"source","obj":"LitCovid-sentences"},{"subj":"T702","pred":"source","obj":"LitCovid-sentences"},{"subj":"T703","pred":"source","obj":"LitCovid-sentences"},{"subj":"T704","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-sentences","color":"#e4ec93","default":true}]}]}}